載入...
Intussusception after Rotavirus Vaccine Introduction in India
BACKGROUND: Rotavac®, an Indian-made, 3-dose, oral rotavirus vaccine, was introduced in the universal immunization program in India in 2016. Pre-licensure safety data for the vaccine were limited to a single trial of 6800 Indian infants; here we report results of a post-marketing surveillance study...
Na minha lista:
| 發表在: | N Engl J Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Massachusetts Medical Society
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7492078/ https://ncbi.nlm.nih.gov/pubmed/33176083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2002276 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|